Insider Transactions in Q1 2026 at Roivant Sciences Ltd. (ROIV)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 20
2026
|
Epperly Melissa B, |
SELL
Payment of exercise price or tax liability
|
Direct |
54
-0.09%
|
$1,188
$22.98 P/Share
|
|
Jan 20
2026
|
Epperly Melissa B, |
BUY
Grant, award, or other acquisition
|
Direct |
815
+1.39%
|
-
|
|
Jan 20
2026
|
Ilan Oren |
SELL
Payment of exercise price or tax liability
|
Direct |
124
-0.1%
|
$2,728
$22.98 P/Share
|
|
Jan 20
2026
|
Ilan Oren |
BUY
Grant, award, or other acquisition
|
Direct |
1,164
+0.96%
|
-
|
|
Jan 20
2026
|
James C Momtazee |
SELL
Payment of exercise price or tax liability
|
Direct |
122
-0.11%
|
$2,684
$22.98 P/Share
|
|
Jan 20
2026
|
James C Momtazee |
BUY
Grant, award, or other acquisition
|
Direct |
609
+0.55%
|
-
|
|
Jan 12
2026
|
Eric Venker President & Immunovant CEO |
SELL
Open market or private sale
|
Direct |
200,000
-10.78%
|
$4,200,000
$21.92 P/Share
|
|
Jan 12
2026
|
Eric Venker President & Immunovant CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
200,000
+9.73%
|
$600,000
$3.85 P/Share
|